BIVI — BioVie Cashflow Statement
0.000.00%
Last trade - 00:00
- $19.33m
- -$3.03m
- 10
- 31
- 21
- 10
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.44 | -16.7 | -130 | -26.1 | -50.3 |
Amortisation | |||||
Non-Cash Items | 0.165 | 14 | 120 | 4.11 | 10 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.452 | 0.774 | 0.019 | 2.76 | -0.233 |
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -2.5 | -1.63 | -10.5 | -19 | -40.3 |
Other Investing Cash Flow Items | — | — | — | — | -14.3 |
Purchase of Investments | |||||
Cash from Investing Activities | — | — | — | — | -14.3 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.8 | 1.33 | 14.9 | 33.1 | 55.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.294 | -0.303 | 4.47 | 14.1 | 0.819 |